Across TCGA pan-cancer cohorts, IGHV4-59 mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of IGHV4-59’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LSCC), where IGHV4-59 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types IGHV4-59 is over-expressed in tumor.
LSCC are the cancer types where IGHV4-59 tumor–normal differential expression is most reproducible.